Form 4 for KYMR Kymera Therapeutics, Inc.
Accepted 2025-10-14 00:00:00 ET · period of report 2025-10-13 · accession 0001193125-25-239144 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-10-14 | 2025-10-13 | KYMR | Gollob Jared | Chief Medical Off | M - OptEx | $1.66 | +1,473 | 120.8K | +1% | +$2,448 |
| DT | 2025-10-14 | 2025-10-13 | KYMR | Gollob Jared | Chief Medical Off | S - Sale+OE | $60.00 | -3,114 | 118.4K | -3% | -$186.8K |
| DMT | 2025-10-14 | 2025-10-13 | KYMR | Gollob Jared | Chief Medical Off | M - OptEx | $0.00 | -1,473 | 22.2K | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-13 | M | A | 673 | $2.08 | 121,473 | D | — | — | |
| 2 | Common | Common Stock | 2025-10-13 | S | D | 3,114 | $60.00 | 118,359 | D | — | — | |
| 3 | Common | Common Stock | 2025-10-13 | M | A | 800 | $1.31 | 120,800 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2025-10-13 | M | D | 800 | $0.00 | 28,999 | D | $1.31 · — to 2028-10-31 | 800 Common Stock | (F2) The shares underlying this stock option are fully vested and exercisable. |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-10-13 | M | D | 673 | $0.00 | 22,210 | D | $2.08 · — to 2029-05-22 | 673 Common Stock | (F2) The shares underlying this stock option are fully vested and exercisable. |